Larynx (and Hypopharynx) Cancer

Cancer can develop in any of these three parts of the larynx:


  • Glottis. (the middle section that holds the vocal cords)

  • Supraglottis. ( the area above the vocal cords)

  • Subglottis. (the area below the vocal cords)

The hypopharynx is the lowest part of the throat that surrounds, and is closely associated with the larynx. Cancers of either the larynx or hypopharynx can have major impact upon eating, breathing and talking.

 
 

95% of cancers in the larynx and hypopharynx are squamous cell carcinomas with laryngeal cancer being one of the most common of the head and neck cancers. As with oropharyngeal cancer, the two most important risk factors for cancer of the larynx/hypopharynx are tobacco and alcohol use. Older men are at greater risk, particularly if there has been occupational exposure to dust, paint fumes or asbestos. Blacks are more likely to get these types of cancer than whites, and some other risk factors include:

  • Poor nutrition (a diet low in Vit. A and E)
  • Gastroesophageal reflux (GERD)
  • Human papilloma virus exposure
  • Plummer-Vinson Syndrome ( a rare condition of iron deficiency and swallowing difficulties

Among the common symptoms of cancers in the larynx/hypopharynx are:

  • Hoarseness of the voice
  • airway blockage
  • persistent sore throat
  • lump in the neck
  • difficulty swallowing
  • ear pain
  • chronic bad breath
  • noisy breathing

Those who experience any of these symptoms should bring them to the doctor's attention. The general doctor's exam may be followed by referral to the head and neck surgeon for further evaluation.

The head and neck surgeon will perform a thorough head and neck exam that will include a form of endoscopy known as laryngoscopy.If an "indirect" laryngoscopy performed with a hand-held mirror is inconclusive or suggestive of a problem, the surgeon will want to take a direct look into the area. Under sedation or full anesthesia, a "direct" laryngoscopy can be performed, allowing the surgeon a complete view of the hypopharynx and upper larynx and the ability to sample (biopsy) suspicious tissues. Many surgeons will advocate a "triple endoscopy" so that they can evaluate the pharynx and larynx, the subglottic larynx and trachea and the esophagus.

When a tumor is found, the surgeon will go on to stage the cancer by use of xrays, CT scan, MRI scan, bone scan or PET scan.

Staging

TNM is an abbreviation for tumor (T), node (N), and metastasis (M). Doctors look at these three factors to determine the stage of cancer.

T0: No evidence of a tumor is found.
Tis: a stage called "carcinoma in situ", a very early cancer found only in the surface layer of tissue.

Glottis
T1: a tumor that is limited to the vocal cords and does not affect cord movement .
T1a: a tumor in just the right or left vocal cord.
T1b: a tumor involving both vocal cords.
T2: a tumor that has spread to the supraglottis or subglottis. or a tumor that affects cord movement.
T3: a tumor limited to the larynx and that affects the vocal cords.
T4a: a tumor that invades the thyroid cartilage or tissues beyond the larynx.
T4b: a tumor that invades the chest and surrounds the arteries.

Supraglottis
T1: a tumor located in a single area above the cords that doesn't affect cord movement.
T2: a tumor that started in this area, but that has spread to the mucus membranes in other areas, (e.g. base of the tongue).
T3: a tumor that is limited to the larynx with vocal cord involvement or has invaded surrounding tissues.
T4a: a tumor that invades the thyroid cartilage or tissues beyond the larynx.
T4b: a tumor that invades the chest area and encases arteries.

Subglottis
T1: a tumor that is limited to the subglottis.
T2: a tumor that extends to the vocal cords and may or may not affect cord movement.
T3: a tumor limited to the larynx that affects the vocal cords.
T4a: a tumor that invades cricoid or thyroid cartilage or invades tissues beyond the larynx.
T4b: a tumor that invades the chest and encases the arteries.

Hypopharynx
T1: a small tumor (2 cm) that is limited to a single site in the hypopharynx.
T2: a tumor that involves more than one site in the hypopharynx, but does not touch the larynx, or a tumor that measures larger than 2 cm but not larger than 4 cm.
T3: a tumor that is larger than 4 cm or one that extends to the larynx.
T4a: a tumor that extends into the adjacent structures, such as the thyroid, carotid vessels or the esophagus.
T4b: a tumor that invades the prevertebral fascia, encases the arteries or involves the mediastinum.

The "N" in the TNM system stands for lymph nodes, the small, bean-shaped organs that help fight infection.

N0: no evidence of cancer in the regional nodes.
N1: cancer has spread to a single node on the same side as the tumor and the cancer in the node is 3 cm or smaller.
N2: any of these following:
N2a: cancer has spread to a single lymph node on the same side as the tumor, is larger than 3 cm, but not larger than 6 cm.
N2b: cancer has spread to more than one node on the same side as the tumor, but none measure larger than 6 cm.
N2c: cancer has spread to more than one lymph node on either side of the neck, but none measure larger than 6 cm.
N3: cancer found in lymph nodes is larger than 6 cm.

The "M" in the TNM system describes cancer that has spread to other parts of the body.

MX: distant metastasis cannot be evaluated.
M0: cancer has not spread to other parts of the body.
M1: cancer t has spread to other parts of the body.

Stages using TNM

Stage 0: carcinoma in situ (Tis), with no spread to lymph nodes (N0) and no distant metastasis (M0).

Stage I: a small tumor (T1), with no spread to lymph nodes (N0) and no distant metastasis (M0).

Stage II: a tumor with some regional extension (T2) that has not spread to lymph nodes (N0) or to distant areas (M0).

Stage III: larger tumors (T3), with no spread to regional lymph nodes (N0) or metastasis (M0), or smaller tumors (T1, T2) that have spread to lymph nodes (N1), but show no sign of metastasis (M0).

Stage IVA: any invasive tumor (T4a), with no lymph node involvement (N0) or spread to only a single same-sided lymph node (N1), but no metastasis (M0). Or, any cancer (T) with more significant nodal involvement (N2), but no metastasis (M0).

Stage IVB: any cancer (T) with extensive nodal involvement (T3), but no metastasis M0).

Stage IVC: evidence of distant spread (M1).

Besides staging a tumor, doctors also assess what is called its "grade." Because normal tissues are made up of many different types of cells grouped together, (something called "differentiation"), tumors are examined microscopically to see if their cells show relatively more or less differentiation. Tumors with less differentiation are more aggressive.

GX: the grade cannot be determined
G1: the cells look more like normal tissue (well differentiated).
G2: the cells are moderately differentiated.
G3: the cells don't look like normal tissue at all (poorly differentiated).

Treatment

The treatment of laryngeal and hypopharyngeal cancer depends on the size and location of the tumor, whether the cancer has spread and the patient's overall health. Although curing the cancer is the primary goal, preserving the function of affected organs is also important. When doctors plan treatment, they consider how it would likely affect a person's quality of life.

Surgery and radiation therapy are both important treatment methods and, in some cases, chemotherapy has a role to play as well.

Surgery can in some cases employ the technique of trans-oral laser microsurgery. This method often allows the surgeon to preserve more normal tissue, but its use is not yet widespread. (A few surgeons like Dr. Caruana have been pioneering the use of this method.)

Standard surgical treatments include partial and total laryngectomy:

Partial laryngectomy removes only part of the larynx. It preserves the voice since only part of the larynx is removed. The following are some different types of partial laryngectomy:

  • "Supraglottic laryngectomy" removes only the area above the vocal cords. If part of the hypopharynx is removed as well this is called a partial pharyngectomy.
  • "Cordectomy" removes a vocal cord.
  • "Vertical hemilaryngectomy" removes one side of the larynx.
  • "Supracricoid partial laryngectomy removes the vocal cords and the areas around them.

Total laryngectomy removes the entire larynx, permanently eliminating speech using the vocal cords.Asa a part of this operation, a permanent opening in the windpipe ( tracheostomy) is made to allow the patient to breathe.

Patients with larger tumors that involve both the larynx and the hypopharynx may require "laryngopharyngectomy." In this surgery, the entire larynx, together with part or all of the hypopharynx is removed. Following this, procedures must be done to reconstruct the pharynx, often using a microsurgically transferred flap of skin or of small intestine.

If there is reason to suspect spread to local lymph nodes, some form of "lymph node dissection" may be carried out. The nature and extent of lymph node removal will vary from removal of just a few nodes near the area of the tumor, to "radical neck dissection" where nearly all neck nodes are removed.

Radiation therapy uses high-energy x-rays to kill cancer cells.The radiation may come from a machine outside the body ("external beam therapy") or from radioactive materials that are put into the tissues through thin plastic tubes or needles (internal radiation therapy, or "bachytherapy"). Radiation may be used as an adjunctive treatment with surgery, or, in some cases, as the primary mode of therapy. Those who stop smoking before radiation therapy have a better chance of surviving longer.

It is important that the head and neck cancer patient who needs radiation be prepared by an oncologic dentist.
(See Dentistry in Head and Neck Cancer)

In some cases, local treatments (surgery and/or radiation) may be supplemented by "systemic" treatment with chemotherapy. Chemotherapy is administered by mouth or by injection, introducing medicines that are able to travel throughout the body and potentially destroy any cancer cells that "broke away" and escaped the local treatment. When this therapy is given after local treatment as a supplement, it is known as "adjuvant" chemotherapy. Treatments given to shrink a tumor before local surgery or radiation are used is called, "neo-adjuvant" therapy.